Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.58 |
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3807521 | 1.00 | CA2 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL2904337 | 1.00 | CA2 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL9933436 | 1.00 | CA2 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL9933922 | 1.00 | CA2 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL20767415 | 1.00 | CA2 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL7223059 | 0.95 | CYP3A4 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL9934623 | 0.95 | CA2 (0.56) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL28900906 | 0.95 | CYP3A4 (0.58) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL3754117 | 0.93 | CA2 (0.52) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL3747389 | 0.93 | CA2 (0.52) | CA2CA1TSHRCYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3632994-B1 | OIL-BASED INKJET INK | RISO KAGAKU CORP (JP) | 2024-01-24 | — | — | EP | claimed |
| CN-110598313-B | Comprehensive energy system optimal configuration method considering energy storage full life cycle operation and maintenance | 国网河北省电力有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-2026100653-A1 | SOLID ROD-LIKE COSMETIC | 三菱鉛筆株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12569426-B2 | Topical skin preparation composition | KAO CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12569427-B2 | Makeup application method | KAO CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20250387307-A1 | PRODUCTION METHOD FOR A SOLID PARTICLE | KAO CORPORATION (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250388477-A1 | PRODUCTION METHOD FOR A SOLID PARTICLE | KAO CORPORATION (JP) | 2025-12-25 | — | — | US | disclosed |
| EP-4066903-B1 | SKIN CLEANSING AGENT | KAO CORP (JP) | 2025-11-05 | — | — | EP | disclosed |
| US-20250228753-A1 | METHOD OF PRODUCING SOLID PARTICLE | KAO CORPORATION (JP) | 2025-07-17 | — | — | US | disclosed |
| CN-115427013-B | External skin preparation composition | 花王株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-118787570-A | Oil gelling agent | 理研维他命株式会社 | 2024-10-18 | — | — | CN | disclosed |
| EP-2550954-A1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | The Nisshin Oillio Group, Ltd. (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130005808-A1 | VASELINE-LIKE COMPOSITION AND COSMETIC | The Nisshin OilliO Group ,Ltd. (JP) | 2013-01-03 | — | — | US | disclosed |
| EP-2494952-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | The Nisshin Oillio Group, Ltd. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-8182828-B2 | Oil-in-water emulsified milky skin cosmetic preparation | SHISEIDO COMPANY LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20100119470-A1 | Method Of Reducing The Appearance Of Wrinkles | SHISEIDO COMPANY, LTD. (JP) | 2010-05-13 | — | — | US | disclosed |
| US-20090202600-A1 | Oil-In-Water Emulsified Milky Skin Cosmetic Preparation | SHISEIDO COMPANY LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20070148120-A1 | Skin preparations for external use for wrinkle reduction | SHISEIDO COMPANY LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1704849-A1 | SKIN PREPARATIONS FOR EXTERNAL USE FOR WRINKLE DIMINUTION | SHISEIDO COMPANY, LTD. (JP) | 2006-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388477-A1 | PRODUCTION METHOD FOR A SOLID PARTICLE | CUTA, LSS, ITK | CA2 4090/4885CA1 4286/4885TSHR 4048/4885 |
| US-20250387307-A1 | PRODUCTION METHOD FOR A SOLID PARTICLE | CUTA, LIPA, TES | CA2 4294/4885CA1 4142/4885TSHR 3721/4885 |
| US-20090202600-A1 | Oil-In-Water Emulsified Milky Skin Cosmetic Preparation | CUTA, ACMSD, MC1R | CA2 2588/4885CA1 3738/4885TSHR 1743/4885 |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKG, MGLL | CA2 3614/4885CA1 4716/4885TSHR 2121/4885 |
| US-20070148120-A1 | Skin preparations for external use for wrinkle reduction | CUTA, MMS19, COL14A1 | CA2 4878/4885CA1 4884/4885TSHR 3084/4885 |
| US-20100119470-A1 | Method Of Reducing The Appearance Of Wrinkles | CUTA, MMS19, COL14A1 | CA2 4878/4885CA1 4884/4885TSHR 3179/4885 |
| US-12569426-B2 | Topical skin preparation composition | KRT18, CUTA, TMSB10 | CA2 2663/4885CA1 3423/4885TSHR 2041/4885 |
| US-12569427-B2 | Makeup application method | LMNB1, LMNB2, PFN1 | CA2 4575/4885CA1 3396/4885TSHR 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.